Yap, T. A., Johannet, P., Chong, G., Hayat, F., Ganju, V., Antill, Y. C., Gollamudi, S., Sadeia, M., Zhang, E., Mobashery, N. (2026). Phase 1/2 study of the novel Werner helicase inhibitor EIK1005 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors, including MSI-H or dMMR tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3170